Assessing the Patient Experience in Cancer Care

NCT01621295 | Completed DMC

• 2 other identifiers: 11-006682R01AT006515
• Study Type: observational
• Target: 408
• Locations: 1 country
• Sites: 3

Brief Summary

Communication is an important component of comprehensive cancer care impacting patient satisfaction, adherence, and quality of life. The wide array of issues addressed in cancer clinical interactions makes communicating about a broad range of topics (including quality of life, communication, symptom control, complementary/alternative therapies, costs, treatment burden, prognosis, anxiety, side-effects, sexual function, palliative care options, etc.) especially interesting and potentially challenging. Some of these topics may not be routinely addressed in the clinical interaction or may require consultative support from other members of the comprehensive cancer care team. One frequently overlooked critical element in research on communication between cancer clinicians, their patients, and their primary care clinicians is describing real-time consultations between patients and their clinicians. These interactions provide rich material for assessing key psycho-social dynamics and identifying issues that patients find important in their care. In order to devise systems of care that optimize the patient experience, it is critical that clinicians and researchers understand, appreciate, and systematically characterize the richness and complexity of the decision-making process in routine cancer consultations between cancer patients and their treating clinicians. This study seeks to assess the patient experience in cancer care by observing patients and their physicians in their clinical interactions and following them for several months to see how their care went. By describing in-depth the conversations and experiences of patients in these clinical interactions, this study will lay the foundation for practice-based interventions to optimize patients' interactions with their cancer care teams.

Conditions

Brain Neoplasm; Breast Neoplasm; Endocrine Gland Neoplasm; Gastrointestinal Neoplasm; Genitourinary Neoplasm; Gynecological Neoplasm; Head and Neck Neoplasm; Lung Neoplasm; Melanoma; Sarcoma

Outcome Measures

Primary Outcomes (1)

• Frequency/duration/content of routine cancer consultations surrounding key topics in the clinical dialogue.

  Key topics to be studied include: quality of life, complementary and alternative therapies, psycho-social characteristics, patient-clinician dynamics, health literacy

  Time of enrollment through completion of 3 month follow-up survey

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Cancer patients age 18 or over receiving care from clinicians who have also consented to participate in this study at Mayo Clinic Rochester, University of Southern California-Norris, or LA County Hospital.

You may qualify if:

• Age greater than or equal to 18 years
• Histological confirmation of: brain, breast, endocrine, gastrointestinal, genitourinary, gynecological, head/neck, lung, melanoma, or sarcoma malignancies.
• Speak English or Spanish
• Not enrolled in hospice
• In any of the following phases of the cancer control continuum: initial diagnosis, initial treatment, early survivorship, or recurrence.
• Provide written informed consent

Sponsors & Collaborators

• Mayo Clinic: lead
• University of Southern California: collaborator
• Johns Hopkins University: collaborator
• National Center for Complementary and Integrative Health (NCCIH): collaborator

Study Sites (3)

Los Angeles County Hospital

Los Angeles, California, 90033, United States

Location

University of Southern California - Norris

Los Angeles, California, 90033, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Brain Neoplasms; Breast Neoplasms; Endocrine Gland Neoplasms; Gastrointestinal Neoplasms; Urogenital Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Sarcoma

Condition Hierarchy (Ancestors)

Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Endocrine System Diseases; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Diseases; Respiratory Tract Diseases; Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms, Connective and Soft Tissue

Study Officials

• Jon C Tilburt, MD, MPH

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PI

Study Record Dates

• First Submitted: June 14, 2012
• First Posted: June 18, 2012
• Study Start: May 1, 2012
• Primary Completion: September 1, 2015
• Study Completion: September 1, 2015
• Last Updated: January 20, 2016

Record last verified: 2016-01

Locations

US (3)